达尔瓦德斯特罗塞尔用于克罗恩病中复杂的近囊:系统性审查和元分析
Carlos Taxonera1, Miguel A García-Brenes1, David Olivares2
1Inflammatory Bowel Disease Unit, Gastroenterology Department, Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos [IdISSC], Madrid, Spain.
United European gastroenterology journal
|October 3, 2024
概括
达尔瓦德斯特罗塞尔是一种干细胞疗法,有效地治愈克罗恩病患者的复杂外囊. 这种治疗方法在观察性研究中显示了持续的疗效和良好的安全性.
科学领域:
- 胃肠病学 胃肠病学
- 再生医学是一种再生医学.
- 细胞疗法细胞疗法
背景情况:
- 克罗恩氏病 (CD) 通常涉及复杂的近鼻,这些很难治疗.
- 达尔瓦德斯特罗塞尔是一种全原性介质干细胞疗法,用于耐火病例.
研究的目的:
- 评估darvadstrocel在克罗恩病患者复杂的近囊治疗中的疗效和安全性.
- 用元分析来综合观察性研究的证据.
主要方法:
- 系统的文献搜索到2024年4月.
- 随机效应对聚合效应大小 (比例,发病率) 的元分析.
- 偏差风险评估和异质性评估 (I2统计).
主要成果:
- 分析了12项涉及595名患者的研究.
- 综合的临床缓解率 (丸愈合) 在6个月后为68.1%,在12个月后为77.2%.
- 一般来说,不良事件的发生率很低,每100个患者年中AEs,严重AEs,围,重复手术的综合发病率分别为19.6,3.2,16.9和7.1.
结论:
- 观测数据支持darvadstrocel在CD中复杂的围囊的疗效和安全性.
- 观察到高且持续的状管愈合率,并具有有利的安全性.
- 在各个研究中,可以忽略不计其数的异质性和一致的治疗效果.
相关概念视频
Chronic Bowel Disorders: Introduction
906
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
906
Drugs for Treatment of Ulcerative Colitis in IBD
721
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
721
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
780
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
703
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
703
Inflammatory Bowel Disease V: Surgical Management
926
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
926
Inflammatory Bowel Disease III: Crohn's Disease
69
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69


